1. Home
  2. MATH vs ICCM Comparison

MATH vs ICCM Comparison

Compare MATH & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Metalpha Technology Holding Limited

MATH

Metalpha Technology Holding Limited

N/A

Current Price

$1.22

Market Cap

52.1M

Sector

Finance

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

N/A

Current Price

$0.67

Market Cap

43.4M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
MATH
ICCM
Founded
2015
2006
Country
Hong Kong
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
52.1M
43.4M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
MATH
ICCM
Price
$1.22
$0.67
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$2.50
AVG Volume (30 Days)
68.0K
136.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$19.87
Revenue Next Year
N/A
$31.38
P/E Ratio
$3.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.10
$0.54
52 Week High
$4.17
$1.53

Technical Indicators

Market Signals
Indicator
MATH
ICCM
Relative Strength Index (RSI) 40.28 58.32
Support Level $1.10 $0.58
Resistance Level $3.16 $0.74
Average True Range (ATR) 0.07 0.04
MACD 0.04 0.01
Stochastic Oscillator 73.68 67.81

Price Performance

Historical Comparison
MATH
ICCM

About MATH Metalpha Technology Holding Limited

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: